A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

September 14, 2018

Primary Completion Date

June 24, 2019

Study Completion Date

June 24, 2019

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

V114

Single 0.5 mL injection

BIOLOGICAL

QIV

Single 0.5 mL injection

BIOLOGICAL

Matching Placebo for V114

Single 0.5 mL injection

Trial Locations (45)

12553

Mid Hudson Medical Research ( Site 0024), New Windsor

13760

Regional Clinical Research, Inc. ( Site 0029), Endwell

14609

Rochester Clinical Research, Inc. ( Site 0009), Rochester

19610

Clinical Research Center Of Reading LLP ( Site 0014), Wyomissing

22911

Charlottesville Medical Research Center, LLC ( Site 0008), Charlottesville

23220

Clinical Research Partners, LLC. ( Site 0005), Richmond

27518

PMG Research Of Cary LLC ( Site 0035), Cary

29464

PMG Research Inc ( Site 0027), Mt. Pleasant

33012

Indago Research & Health Center, Inc ( Site 0007), Hialeah

33014

Lakes Research LLC ( Site 0034), Miami Lakes

33024

Research Centers of America, LLC ( Site 0036), Hollywood

33135

Suncoast Research Group, LLC ( Site 0020), Miami

33144

L&C Professional Medical Research Institute ( Site 0015), Miami

33186

Alpha Science Research ( Site 0018), Miami

35216

Achieve Clinical Research, LLC ( Site 0046), Birmingham

37203

Clinical Research Associates Inc. ( Site 0040), Nashville

37620

Holston Medical Group ( Site 0003), Bristol

37660

Holston Medical Group ( Site 0028), Kingsport

40004

Kentucky Pediatric/Adult Research Inc ( Site 0011), Bardstown

53226

Allegiance Research Specialists ( Site 0017), Wauwatosa

60201

Evanston Premier Healthcare & Research, LLC. ( Site 0012), Evanston

60422

Healthcare Research Network LLC ( Site 0006), Flossmoor

62703

Springfield Clinic ( Site 0045), Springfield

63042

Healthcare Research Network LLC ( Site 0032), Hazelwood

67010

Heartland Research Associates, LLC ( Site 0031), Augusta

67114

Heartland Research Associates, LLC ( Site 0016), Newton

73052

Unity Clinical Research ( Site 0044), Lindsay

75013

Wellness Clinical Research Associates ( Site 0048), Allen

76135

Benchmark Research ( Site 0037), Fort Worth

78229

Synexus Clinical Research US, Inc. ( Site 0019), San Antonio

78626

San Gabriel Clinical Research ( Site 0047), Georgetown

80909

Synexus Clinical Research US, Inc./Colorado Springs Family Practice ( Site 0021), Colorado Springs

85206

Synexus Clinical Research, US,Inc/Central Arizona Medical Associates, PC ( Site 0004), Mesa

85224

Synexus Clinical Research US, Inc. ( Site 0039), Chandler

85251

Synexus Clinical Research US, Inc. ( Site 0042), Scottsdale

87505

Southwest CARE Center ( Site 0013), Santa Fe

89104

Clinical Research Center of Neveda, LLC. ( Site 0022), Las Vegas

90723

Center for Clinical Trials, LLC ( Site 0025), Paramount

91325

Valley Clinical Trials Inc. ( Site 0001), Northridge

91607

Bayview Research Group, LLC ( Site 0010), Valley Village

92103

Artemis Institute for Clinical Research ( Site 0026), San Diego

92123

California Research Foundation ( Site 0002), San Diego

92708

Southland Clinical Research Center ( Site 0033), Fountain Valley

01752

Community Clinical Research Network (Marlboro, MA) ( Site 0030), Marlborough

02886

Omega Medical Research ( Site 0049), Warwick

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT03615482 - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU) | Biotech Hunter | Biotech Hunter